These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Homozygous deletion of CDKN2/p16 gene in lung cancers].
    Author: Su C, Ye Y, Cao X, Shan X.
    Journal: Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 1999 Oct; 16(5):315-7. PubMed ID: 10514540.
    Abstract:
    OBJECTIVE: To study the relationship between CDKN2/p16 gene homozygous deletion and lung cancer progression. METHODS: Improved multiplex PCR technique was applied to detect deletion of CDKN2/p16 gene exon1 and exon2 in 89 cases of lung cancers. RESULTS: Gene deletion rate was increased by the improved PCR technique. Exon 1 and exon 2 deletion rates were 19.1% (17/89) and 22.5% (20/89) respectively, with total rate of exon1 and/or exon2 deletion 25.8% (23/89). Deletion of CDKN2/p16 gene occurred in non-small cell lung carcinoma (NSCLC) and was related to metastasis and progressive stage. CONCLUSION: Abnormality of CDKN2/p16 gene is a genetic factor for NSCLC susceptibility, and may play a role to some extent in NSCLC malignant progression.
    [Abstract] [Full Text] [Related] [New Search]